International Papillomavirus Society Invites Dr. Krishnan to Speak at Conference
Aseemkala and GIAHC Present the Voices of Patients in a Dance-Medicine Narrative
January is Cervical Cancer Awareness Month
Dr. Krishnan Returns from Asia Trip
University of Malaya Update

What We Do


We believe that a woman is the nucleus of her family, and when she becomes ill or dies, her children, family and community suffer. We work with programs to minimize these far-reaching consequences. 

  • Build relationships to develop, strengthen and support HPV and cervical cancer prevention, screening and treatment programs: With the use of knowledge and talents of local and international health and allied workers, we aim to strengthen existing systems where available, and support the development of new ones that are practical and can be integrated optimally where necessary. This comprehensive care service is delivered to the population year-round.
  • Promote health education: Assist with the development of culturally sensitive and linguistically appropriate health education materials.
  • Training: Co-host training workshops on a periodic basis to train community health workers (physicians, nurses and other qualified health personnel) on cervical cancer education, screening and early treatment.
  • Engage communities in screening and early treatment programs: Identify barriers and help communities implement creative, medically sound, economically sustainable, practical solutions for effective management of screening, early treatment and referral base for advanced cervical cancers.

We promote models that work on the principle of task shifting: to shift less sophisticated procedures such as cervical cancer screening and early treatment from highly trained professionals (such as physicians) to nurses and community health workers (CHWs) with appropriate training. This is essential, particularly in regions of the world where there are acute shortages in human resources.

Our partners and collaborators are currently using visual inspection with acetic acid (VIA) to detect early precancerous changes. Treatment is then followed by “cryotherapy” (freezing of cells) when appropriate. Those with advanced disease are referred to clinics and hospitals in the area wherever possible.

In the near future, we hope to introduce objective, more accurate cost effective technologies such as HPV DNA testing and biomarkers that identify host cell integration as a precursor to cervical pre-cancer and cancer.